Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 6 of 6 entries
View as:
LGX818 in Combination With Agents (MEK162; BKM120; LEE011; BGJ398; INC280) in Advanced BRAF Melanoma
Phase: N/A
Priority: Normal
Start: 11/30/13
End: 03/31/15
Due: 03/31/16
Phase: N/A
Priority: Normal
Start: 12/31/14
End: 06/23/17
Due: 06/23/18
Phase: N/A
Priority: Normal
Start: 03/31/12
End: 08/15/17
Due: 08/15/18
Phase: N/A
Priority: Normal
Start: 03/31/09
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/09
End: 02/28/11
Due: 02/28/12
Phase: N/A
Priority: Normal
Start: 07/31/13
End: 04/30/15
Due: 04/30/16